1 Introduction to Research & Analysis Reports 1.1 Bone and Mineral Metabolism Disorders Treatment Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Bone and Mineral Metabolism Disorders Treatment Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Bone and Mineral Metabolism Disorders Treatment Overall Market Size 2.1 United States Bone and Mineral Metabolism Disorders Treatment Market Size: 2021 VS 2027 2.2 United States Bone and Mineral Metabolism Disorders Treatment Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Bone and Mineral Metabolism Disorders Treatment Players in United States Market 3.2 Top United States Bone and Mineral Metabolism Disorders Treatment Companies Ranked by Revenue 3.3 United States Bone and Mineral Metabolism Disorders Treatment Revenue by Companies 3.4 Top 3 and Top 5 Bone and Mineral Metabolism Disorders Treatment Companies in United States Market, by Revenue in 2020 3.5 Companies Bone and Mineral Metabolism Disorders Treatment Product Type 3.6 Tier 1, Tier 2 and Tier 3 Bone and Mineral Metabolism Disorders Treatment Players in United States Market 3.6.1 List of Tier 1 Bone and Mineral Metabolism Disorders Treatment Companies in United States 3.6.2 List of Tier 2 and Tier 3 Bone and Mineral Metabolism Disorders Treatment Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Bone and Mineral Metabolism Disorders Treatment Market Size Markets, 2021 & 2027 4.1.2 Bisphosphonates 4.1.3 Estrogens 4.1.4 Phosphate Binders 4.1.5 Non-Calcium, Non-Metal-Based Binder 4.1.6 Metal-Based Binders 4.1.7 Magnesium-Based Binders 4.1.8 Vitamin D Analogs and Supplements 4.1.9 Calcimimetic Agents 4.1.10 Calcium and Magnesium Supplements 4.2 By Type - United States Bone and Mineral Metabolism Disorders Treatment Revenue & Forecasts 4.2.1 By Type - United States Bone and Mineral Metabolism Disorders Treatment Revenue, 2016-2021 4.2.2 By Type - United States Bone and Mineral Metabolism Disorders Treatment Revenue, 2022-2027 4.2.3 By Type - United States Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Bone and Mineral Metabolism Disorders Treatment Market Size, 2021 & 2027 5.1.2 Hospital Pharmacies 5.1.3 Retail Pharmacies 5.1.4 Online Pharmacies 5.1.5 Drug Stores 5.2 By Application - United States Bone and Mineral Metabolism Disorders Treatment Revenue & Forecasts 5.2.1 By Application - United States Bone and Mineral Metabolism Disorders Treatment Revenue, 2016-2021 5.2.2 By Application - United States Bone and Mineral Metabolism Disorders Treatment Revenue, 2022-2027 5.2.3 By Application - United States Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2016-2027 6 Bone and Mineral Metabolism Disorders Treatment Companies Profiles 6.1 Merck 6.1.1 Merck Company Details 6.1.2 Merck Business Overview 6.1.3 Merck Bone and Mineral Metabolism Disorders Treatment Introduction 6.1.4 Merck Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) 6.1.5 Merck Recent Developments 6.2 F. Hoffmann-La Roche 6.2.1 F. Hoffmann-La Roche Company Details 6.2.2 F. Hoffmann-La Roche Business Overview 6.2.3 F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Introduction 6.2.4 F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) 6.2.5 F. Hoffmann-La Roche Recent Developments 6.3 Novartis 6.3.1 Novartis Company Details 6.3.2 Novartis Business Overview 6.3.3 Novartis Bone and Mineral Metabolism Disorders Treatment Introduction 6.3.4 Novartis Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) 6.3.5 Novartis Recent Developments 6.4 Warner Chilcott 6.4.1 Warner Chilcott Company Details 6.4.2 Warner Chilcott Business Overview 6.4.3 Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Introduction 6.4.4 Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) 6.4.5 Warner Chilcott Recent Developments 6.5 Sanofi 6.5.1 Sanofi Company Details 6.5.2 Sanofi Business Overview 6.5.3 Sanofi Bone and Mineral Metabolism Disorders Treatment Introduction 6.5.4 Sanofi Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) 6.5.5 Sanofi Recent Developments 6.6 AbbVie 6.6.1 AbbVie Company Details 6.6.2 AbbVie Business Overview 6.6.3 AbbVie Bone and Mineral Metabolism Disorders Treatment Introduction 6.6.4 AbbVie Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) 6.6.5 AbbVie Recent Developments 6.7 Amgen 6.7.1 Amgen Company Details 6.7.2 Amgen Business Overview 6.7.3 Amgen Bone and Mineral Metabolism Disorders Treatment Introduction 6.7.4 Amgen Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) 6.7.5 Amgen Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Bone and Mineral Metabolism Disorders Treatment Market Opportunities & Trends in United States Market Table 2. Bone and Mineral Metabolism Disorders Treatment Market Drivers in United States Market Table 3. Bone and Mineral Metabolism Disorders Treatment Market Restraints in United States Market Table 4. Key Players of Bone and Mineral Metabolism Disorders Treatment in United States Market Table 5. Top Bone and Mineral Metabolism Disorders Treatment Players in United States Market, Ranking by Revenue (2019) Table 6. United States Bone and Mineral Metabolism Disorders Treatment Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Bone and Mineral Metabolism Disorders Treatment Revenue Share by Companies, 2016-2021 Table 8. Companies Bone and Mineral Metabolism Disorders Treatment Product Type Table 9. List of Tier 1 Bone and Mineral Metabolism Disorders Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Bone and Mineral Metabolism Disorders Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – United States Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - United States Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn), 2016-2021 Table 13. By Type - United States Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn), 2022-2027 Table 14. By Application – United States Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn), 2022-2027 Table 17. Merck Company Details Table 18. Merck Business Overview Table 19. Merck Bone and Mineral Metabolism Disorders Treatment Product Table 20. Merck Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 21. Merck Recent Developments Table 22. F. Hoffmann-La Roche Company Details Table 23. F. Hoffmann-La Roche Business Overview Table 24. F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Product Table 25. F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 26. F. Hoffmann-La Roche Recent Developments Table 27. Novartis Company Details Table 28. Novartis Business Overview Table 29. Novartis Bone and Mineral Metabolism Disorders Treatment Product Table 30. Novartis Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 31. Novartis Recent Developments Table 32. Warner Chilcott Company Details Table 33. Warner Chilcott Business Overview Table 34. Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Product Table 35. Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Warner Chilcott Recent Developments Table 37. Sanofi Company Details Table 38. Sanofi Business Overview Table 39. Sanofi Bone and Mineral Metabolism Disorders Treatment Product Table 40. Sanofi Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 41. Sanofi Recent Developments Table 42. AbbVie Company Details Table 43. AbbVie Business Overview Table 44. AbbVie Bone and Mineral Metabolism Disorders Treatment Product Table 45. AbbVie Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 46. AbbVie Recent Developments Table 47. Amgen Company Details Table 48. Amgen Business Overview Table 49. Amgen Bone and Mineral Metabolism Disorders Treatment Product Table 50. Amgen Bone and Mineral Metabolism Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million) Table 51. Amgen Recent Developments List of Figures Figure 1. Bone and Mineral Metabolism Disorders Treatment Segment by Type Figure 2. Bone and Mineral Metabolism Disorders Treatment Segment by Application Figure 3. United States Bone and Mineral Metabolism Disorders Treatment Market Overview: 2020 Figure 4. United States Bone and Mineral Metabolism Disorders Treatment Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Bone and Mineral Metabolism Disorders Treatment Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Bone and Mineral Metabolism Disorders Treatment Revenue in 2020 Figure 7. By Type - United States Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2016-2027 Figure 8. By Application - United States Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2016-2027 Figure 9. Merck Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Novartis Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Sanofi Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. AbbVie Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. Amgen Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Merck F. Hoffmann-La Roche Novartis Warner Chilcott Sanofi AbbVie Amgen